At the quarterly meeting of the Daxor Corp.'s board of directors held on September 21, 2016, it was unanimously voted by the board to appoint Michael Feldschuh as the permanent president and chief executive officer of the Daxor Corporation. Being a board member, Michael Feldschuh abstained from voting. Michael has served as acting president and chief executive officer since December, 2015.

The previous president and chief executive officer of the Daxor Corporation, Dr. Joseph Feldschuh, voluntarily stepped down due to ongoing medical issues. Dr. Feldschuh will continue as the company's chairman of the board and chief financial officer.